Exploring pediatric onset Still’s disease patient journey and parental perceptions in Türkiye through a survey

This survey-based study aimed to explore the journey to the diagnosis and management of children with pediatric onset Still’s disease (PoSD) in Türkiye. This sought to understand parents’ perceptions, feelings, and expectations, enabling the identification of unmet needs and fostering improvements in PoSD care. A 42-question survey was administered to patients (< 21 years) with PoSD or their parents (the primary caregiver of each child younger than middle school age) by pediatric rheumatologists, during their clinic visits between January and May 2024. Data were descriptively analyzed. The study included 39 children (mean age: 9.92 ± 4.93 years; 66.7% female). Ten children and 29 parents completed the survey. Persistent fever (84.6%), swollen joints and rash (64.1% each) were the most common initial manifestations. No patient received the diagnosis of PoSD at their initial visit: two-thirds were referred to other physicians and one-third were misdiagnosed, primarily with other inflammatory conditions (15.4%) and infections (12.8%). The median diagnostic delay was 1 (1–4) months. At the time of the survey, 21 patients (53.8%) had been receiving biologics (monthly (n = 10), bimonthly or weekly (n = 5, each) injections); 19 patients were compliant with this treatment. Seven patients (17.9%) had used biologics in past. PoSD substantially affected psychological well-being (33.3%) and daily tasks (13%). Fifteen of 26 school-age children missed school for a mean of 17.7 ± 15.9 days/year due to PoSD. Most parents (90%) had not heard of PoSD at the time of diagnosis. Overall, 28% of parents hardly accepted the diagnosis. PoSD worsening in the future was their main concern (68.9%). The parents’/patients’ primary expectation was to achieve a cure (82.1%). The main sources of information for parents were the physicians treating their children (96.6%), internet (72.4%) and other patient relatives (20.7%). This survey of the PoSD patient journey in Türkiye identified several areas of improvement for better disease management. It underscores the need for enhanced continuous medical education for physicians and parental awareness of PoSD, higher access to credible information resources, and greater parental engagement in activities organized by pediatric rheumatology associations. Collecting quantitative and qualitative data on various aspects of PoSD could further refine approaches to optimize patient care.

Authors

Institutions

Publication Details

Journal
Pediatric Rheumatology
Published
2025-10-14
DOI
https://doi.org/10.1186/s12969-025-01155-7
Primary Topic
Autoimmune and Inflammatory Disorders Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Exploring pediatric onset Still’s disease patient journey and parental perceptions in Türkiye through a survey

Berkant Ersoy, Nergis Akay, Kübra Uçak, Mehmet Yıldız et al.
Pediatric Rheumatology
Autoimmune and Inflammatory Disorders Research
article

Exploring pediatric onset Still’s disease patient journey and parental perceptions in Türkiye through a survey

Berkant Ersoy, Nergis Akay, Kübra Uçak, Mehmet Yıldız, Nihal Şahin Uysal, Banu Çelikel Acar, Sara Şebnem Kılıç, Emel Aslan, Boran Can Saraçoğlu, Özgür Kasapçopur, Ümit Gül, Elif Çelikel, Hatice Kubra Zora
article en

Abstract

This survey-based study aimed to explore the journey to the diagnosis and management of children with pediatric onset Still’s disease (PoSD) in Türkiye. This sought to understand parents’ perceptions, feelings, and expectations, enabling the identification of unmet needs and fostering improvements in PoSD care. A 42-question survey was administered to patients (< 21 years) with PoSD or their parents (the primary caregiver of each child younger than middle school age) by pediatric rheumatologists, during their clinic visits between January and May 2024. Data were descriptively analyzed. The study included 39 children (mean age: 9.92 ± 4.93 years; 66.7% female). Ten children and 29 parents completed the survey. Persistent fever (84.6%), swollen joints and rash (64.1% each) were the most common initial manifestations. No patient received the diagnosis of PoSD at their initial visit: two-thirds were referred to other physicians and one-third were misdiagnosed, primarily with other inflammatory conditions (15.4%) and infections (12.8%). The median diagnostic delay was 1 (1–4) months. At the time of the survey, 21 patients (53.8%) had been receiving biologics (monthly (n = 10), bimonthly or weekly (n = 5, each) injections); 19 patients were compliant with this treatment. Seven patients (17.9%) had used biologics in past. PoSD substantially affected psychological well-being (33.3%) and daily tasks (13%). Fifteen of 26 school-age children missed school for a mean of 17.7 ± 15.9 days/year due to PoSD. Most parents (90%) had not heard of PoSD at the time of diagnosis. Overall, 28% of parents hardly accepted the diagnosis. PoSD worsening in the future was their main concern (68.9%). The parents’/patients’ primary expectation was to achieve a cure (82.1%). The main sources of information for parents were the physicians treating their children (96.6%), internet (72.4%) and other patient relatives (20.7%). This survey of the PoSD patient journey in Türkiye identified several areas of improvement for better disease management. It underscores the need for enhanced continuous medical education for physicians and parental awareness of PoSD, higher access to credible information resources, and greater parental engagement in activities organized by pediatric rheumatology associations. Collecting quantitative and qualitative data on various aspects of PoSD could further refine approaches to optimize patient care.

Pediatric RheumatologyVol. 23(1)
Novartis (Switzerland) (CH), Bursa Uludağ Üni̇versi̇tesi̇ (TR), University of Health Science (KH), Istanbul University-Cerrahpaşa (TR), Başkent University Hospital (TR), Sağlık Bilimleri Üniversitesi (TR), Kocaeli Üniversitesi (TR)
Openalex Percentile: Top 63%
Autoimmune and Inflammatory Disorders Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.